首页 | 本学科首页   官方微博 | 高级检索  
   检索      

重组百日咳杆菌黏附素蛋白免疫小鼠可完全抵抗支气管败 血波氏杆菌的致死性感染
引用本文:赵战勤,薛云,吴斌,段龙川,陈焕春,汤细彪,胡睿铭,何华,李增强.重组百日咳杆菌黏附素蛋白免疫小鼠可完全抵抗支气管败 血波氏杆菌的致死性感染[J].微生物学报,2008,48(3):337-341.
作者姓名:赵战勤  薛云  吴斌  段龙川  陈焕春  汤细彪  胡睿铭  何华  李增强
作者单位:华中农业大学动物医学院,农业微生物学国家重点实验室,武汉,430070
基金项目:国家自然科学基金 , 国家高技术研究发展计划(863计划)
摘    要:目的]通过建立的小鼠呼吸道感染模型评价重组百日咳杆菌黏附素蛋白(GST-PRN)对小鼠的免疫保护效力.方法和结果]在主动免疫保护试验中,GST-PRN免疫组小鼠能产生较高的PRN抗体水平,在使用3xLD50的支气管败血波氏杆菌HH0809株进行呼吸道气雾攻毒后,其保护率为100%(20/20),但载体蛋白GST和PBS对照组小鼠的存活率仅为15%(3/20)和20%(4/20).在被动免疫保护试验中,腹腔免疫GST-PRN兔抗血清能100%(10/10)保护小鼠抵抗10×LD50的HH0809株的腹腔攻击,但GST兔抗血清和PBS免疫组小鼠的存活率均为0(0/10和0/9).结论]研究结表明重组PRN蛋白具有良好的免疫学活性,可作为亚单位疫苗或疫苗添加成分.

关 键 词:支气管败血波氏杆菌  百日咳杆菌黏附素  免疫原性  重组  百日咳  波氏杆菌  黏附素蛋白  蛋白免疫  小鼠  完全  抵抗  支气管  致死性感染  antigens  recombinant  immunization  infection  添加成分  亚单位疫苗  活性  免疫学  研究  腹腔免疫
文章编号:0001-6209(2008)03-0337-05
收稿时间:2007-07-06
修稿时间:2007-12-19

Protecting mice from fatal Bordetella bronchiseptica infection by immunization with recombinant pertactin antigens
Zhanqin Zhao,Yun Xue,Bin Wu,Longchuan Duan,Huanchun Chen,Xibiao Tang,Ruiming Hu,Hua He and Zengqiang Li.Protecting mice from fatal Bordetella bronchiseptica infection by immunization with recombinant pertactin antigens[J].Acta Microbiologica Sinica,2008,48(3):337-341.
Authors:Zhanqin Zhao  Yun Xue  Bin Wu  Longchuan Duan  Huanchun Chen  Xibiao Tang  Ruiming Hu  Hua He and Zengqiang Li
Institution:State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China;State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan 430070, China
Abstract:OBJECTIVE: We evaluated the efficacy of the recombinant pertactin (PRN)-specific active or passive immunization against Bordetella bronchiseptica (Bb) in an aerosol challenge model established by using BALB/c mice. METHODS AND RESULTS: Mice, immunized subcutaneously with two doses of purified glutathione S-transferase (GST)-PRN protein mixed with an equal volume of Freund's adjuvant, produced robust PRN-specific IgG antibody activity. All 20 mice vaccinated with GST-PRN protein survived aerosol challenge with three times the 50% lethal dose (LD50) of virulent Bb HH0809 compared with 3 of 20 GST protein-treated controls and 4 of 20 PBS-treated controls that survived. Furthermore, we observed complete protection against intraperitoneal challenge with ten times the LD50 of virulent HH0809 strain in mice that were injected intraperitoneally with 0.5 ml rabbit anti-GST-PRN serum. No survivors were observed in mice that received either rabbit anti-GST serum or PBS alone. CONCLUSION: The recombinant PRN protein had strong immunogenicity against Bb infection.
Keywords:Bordetella bronchiseptica  pertactin  immunogenicity
本文献已被 万方数据 等数据库收录!
点击此处可从《微生物学报》浏览原始摘要信息
点击此处可从《微生物学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号